Anmelden

Daniel Junker

NMI Natural and Medical Sciences Institute

University of Tübingen

BIOGRAPHY

Daniel Junker has not added Biography.

If you are Daniel Junker and would like to personalize this page please email our Author Liaison for assistance.

PUBLICATIONS

SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognition.

Nature immunology Jan, 2021 | Pubmed ID: 32999467

Exploring beyond clinical routine SARS-CoV-2 serology using MultiCoV-Ab to evaluate endemic coronavirus cross-reactivity.

Nature communications Feb, 2021 | Pubmed ID: 33608538

Multiplexed Serum Antibody Screening Platform Using Virus Extracts from Endemic and SARS-CoV-2.

ACS infectious diseases Jun, 2021 | Pubmed ID: 33724771

Immune response to SARS-CoV-2 variants of concern in vaccinated individuals.

Nature communications May, 2021 | Pubmed ID: 34035301

Biparatopic nanobodies protect mice from lethal challenge with SARS-CoV-2 variants of concern.

EMBO reports Feb, 2022 | Pubmed ID: 34927793

Evidence for increased SARS-CoV-2 susceptibility and COVID-19 severity related to pre-existing immunity to seasonal coronaviruses.

Cell reports Dec, 2021 | Pubmed ID: 34932974

Robust and durable serological response following pediatric SARS-CoV-2 infection.

Nature communications Jan, 2022 | Pubmed ID: 35013206

Diminishing Immune Responses against Variants of Concern in Dialysis Patients 4 Months after SARS-CoV-2 mRNA Vaccination.

Emerging infectious diseases Apr, 2022 | Pubmed ID: 35203113

Comparative Magnitude and Persistence of Humoral SARS-CoV-2 Vaccination Responses in the Adult Population in Germany.

Frontiers in immunology , 2022 | Pubmed ID: 35251012

COVID-19 patient serum less potently inhibits ACE2-RBD binding for various SARS-CoV-2 RBD mutants.

Scientific reports May, 2022 | Pubmed ID: 35505068

Longitudinal cellular and humoral immune responses after triple BNT162b2 and fourth full-dose mRNA-1273 vaccination in haemodialysis patients.

Frontiers in immunology , 2022 | Pubmed ID: 36275672

Borrelia multiplex: a bead-based multiplex assay for the simultaneous detection of Borrelia specific IgG/IgM class antibodies.

BMC infectious diseases Nov, 2022 | Pubmed ID: 36396985

Diminished neutralization responses towards SARS-CoV-2 Omicron VoC after mRNA or vector-based COVID-19 vaccinations.

Scientific reports Nov, 2022 | Pubmed ID: 36400804

INSTITUTIONS

University of Tübingen

NMI Natural and Medical Sciences Institute at the University of Tübingen

JOVE ARTICLES

Simultaneous Detection of Different Antibody Classes in a Multiplexed Serological Test

Julia Häring^*,1,

Tanja Michel^*,1,

Matthias Becker¹,

Daniel Junker¹,

Tatia Tchitchagua²,

Olaf Leschnik²,

Berit Lange^3,4,

Stefanie Castell^3,4,

Gérard Krause^3,4,

Monika Strengert³,

Alex Dulovic¹,

Nicole Schneiderhan-Marra¹

¹, NMI Natural and Medical Sciences Institute at the University of Tübingen,

²Department of Neurology, Sächsisches Krankenhaus Rodewisch,

³Department of Epidemiology, Helmholtz Centre for Infection Research,

⁴, German Centre for Infection Research (DZIF)

Immunology and Infection

Datenschutz

Nutzungsbedingungen

Richtlinien

Kontakt

BIBLIOTHEKS-EMPFEHLUNG

JoVE-Newsletter

Forschung

JoVE Journal
Methodensammlungen
JoVE Encyclopedia of Experiments
Archiv

Lehre

JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Ressourcen für Lehrende
Faculty Site

Autoren

Übersicht
Veröffentlichungsprozess
Redaktionsausschuss
Umfang und Richtlinien
Peer Review
Häufig gestellte Fragen
Einreichen

Bibliothekare

Übersicht
Erfahrungsberichte
Lizenzen
Zugang
Ressourcen
Bibliotheksbeirat
Häufig gestellte Fragen

ÜBER JoVE

Übersicht
Geschäftsführung
Blog
JoVE Help Center

Daniel Junker

.css-o250i3{font-size:18px;font-family:Open Sans,sans-serif;line-height:21.6px;}NMI Natural and Medical Sciences Institute

University of Tübingen

Simultaneous Detection of Different Antibody Classes in a Multiplexed Serological Test

NMI Natural and Medical Sciences Institute